-
Mashup Score: 13Why it is hard to use PROMs and PREMs in routine health and care - 3 month(s) ago
Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) show the results of healthcare activities as rated by patients and others. Patients or their proxies record feedback using questionnaires. These can enhance quality for all and tailored care for individuals. This paper describes obstacles that inhibit widespread use of PROMs and PREMs and some potential solutions. Implementation is a prerequisite for any innovation to succeed. Health and care services are complex and people need to be engaged at every level. Most people are cautious about proven innovations such as PROMs and PREMs but champions and leaders can help them engage. The NASSS framework (reasons for Non-adoption, Abandonment and failure to Scale up, Spread or Sustain digital health innovations) helps indicate that implementation is complex why it may be resisted. The Plan-Do-Study-Act (PDSA) approach aids implementation and helps ensure that everyone knows who should do what, when, whe
Source: bmjopenquality.bmj.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 0Patient-Reported Outcomes and Function After Surgical Repair of the Ulnar Collateral Ligament of the Thumb - 8 month(s) ago
The purpose of this study was to report prospectively collected patient-reported outcomes of patients who underwent open thumb ulnar collateral ligament (UCL) repair and to find risk factors associated with poor patient-reported outcomes.
Source: www.jhandsurg.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 3Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy - 8 month(s) ago
Key Points. QOL and depression worsened soon after CAR-T, but QOL, psychological distress, and physical symptoms improved 6 months after CAR-T.A significant min
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Background Quality of Life (QoL) is a prognostic factor in heart failure (HF) of patients with acquired cardiac disease. The aim of this study was to determine the predictive value of QoL on outcomes in adults with congenital heart disease (ACHD) and HF. Methods and Results Quality of life of 196 ad …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4My Clinical Outcomes — UHS NHS Trust - 12 month(s) ago
University Hospitals Sussex Using Digital PROMs as Key Part of New Enhanced Supportive Care Service University Hospitals Sussex NHS Foundation Trust are using MCO as part of an Enhanced Supportive Care (ESC) project to get advanced visibility of Quality of Life data from patients who are asked to register by oncology colleagues prior to a referral to palliative care.Project Video: Clinicians and…
Source: My Clinical OutcomesCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 2
Objective To evaluate the frequency with which relevant and accurate information about the benefits and related uncertainties of anticancer drugs are communicated to patients and clinicians in regulated information sources in Europe. Design Document content analysis. Setting European Medicines Agency. Participants Anticancer drugs granted a first marketing authorisation by the European…
Source: The BMJCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes - 1 year(s) ago
Background: Chemotherapy-induced peripheral neurotoxicity (CIPN) is a common complication of cancer treatment that produces functional disability. Increasingly, patient-reported outcome measures (PROMs) are used to assess CIPN, providing a broader symptom perspective than clinician-graded scales. Understanding when a reported change in CIPN symptoms meets the threshold for clinical significance…
Source: JNCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
This cross-sectional study investigates the use of patient-reported outcome measures in new marketing authorizations for oncology drugs approved by the European Medicines Agency (EMA) between 2017 and 2021.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 3Patient-reported outcome measures in cardiovascular disease have limited validation of psychometric properties | 2 Minute Medicine - 1 year(s) ago
1. In 50 patient-reported outcome measures evaluated, only a small minority reported the validation of all Food and Drug Administration (FDA)-recommended psychometric properties. 2. Patient-reported outcome measures (PROMs) rarely had psychometric properties rated as sufficient by consensus-based standards. Evidence Rating Level: 1 (Excellent) Study Rundown: PROs are reported directly by patients…
Source: 2 Minute MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Patient-reported outcome measures in cardiovascular disease have limited validation of psychometric properties | 2 Minute Medicine - 1 year(s) ago
1. In 50 patient-reported outcome measures evaluated, only a small minority reported the validation of all Food and Drug Administration (FDA)-recommended psychometric properties. 2. Patient-reported outcome measures (PROMs) rarely had psychometric properties rated as sufficient by consensus-based standards. Evidence Rating Level: 1 (Excellent) Study Rundown: PROs are reported directly by patients…
Source: 2 Minute MedicineCategories: Cardiologists, Latest HeadlinesTweet
Why it is hard to use PROMs and PREMs in routine health and care | BMJ Open Quality PDSA approach to introducing change fell out of fashion - deserves a re look #proms @FallowfieldLJ @LesleyLesleys https://t.co/8iJdm7m4bZ